BOSTON & MONTREAL-- enGene Holdings Inc. (Nasdaq: ENGN) has announced the issuance of inducement equity awards to four newly-hired employees, including Chief Global Commercialization Officer Amy Pott, with a grant date of June 16, 2025. Ms. Pott received a non-qualified stock option to purchase 400,000 common shares, while the other three employees were granted options for a total of 53,450 shares. Each stock option, carrying an exercise price of $3.31 per share, has a 10-year term and vests over four years. The options were approved by the independent Compensation Committee of the Board of Directors under NASDAQ Listing Rule 5635(c)(4).
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.